Table 3 Univariate survival analysis of 99 patients with extremity soft tissue sarcoma
| Â | No. | 5-year OS | 5-year DFS | 5-year LRFS | 5-year DMFS | ||||
|---|---|---|---|---|---|---|---|---|---|
% | P value | % | P value | % | P value | % | P value | ||
Age (years) | |||||||||
  ≤ 60 | 74 | 85.9 | < 0.001 | 77.4 | 0.001 | 89.4 | 0.236 | 84.4 | 0.002 |
  > 60 | 25 | 52.0 |  | 43.2 |  | 83.6 |  | 55.7 |  |
Tumor size (cm) | |||||||||
  ≤ 5 | 34 | 87.5 | 0.130 | 78.0 | 0.229 | 96.7 | 0.162 | 84.2 | 0.263 |
  > 5 | 61 | 69.8 |  | 63.5 |  | 82.3 |  | 71.8 |  |
Tumor depth | |||||||||
 Superficial | 30 | 89.3 | 0.205 | 79.0 | 0.300 | 92.6 | 0.734 | 86.2 | 0.296 |
 Deep | 69 | 71.9 |  | 65.8 |  | 86.2 |  | 73.2 |  |
FNCLCC grade | |||||||||
 1–2 | 67 | 84.8 | 0.012 | 81.5 | < 0.001 | 93.4 | 0.008 | 84.5 | 0.003 |
 3 | 32 | 60.2 |  | 44.8 |  | 75.3 |  | 61.4 |  |
Resection margin | |||||||||
 Negative | 77 | 80.0 | 0.065 | 73.6 | 0.109 | 93.9 | 0.001 | 78.9 | 0.202 |
 Close or Positive | 19 | 67.4 |  | 52.6 |  | 65.1 |  | 68.0 |  |
Chemotherapy | |||||||||
 No | 58 | 80.2 | 0.522 | 73.0 | 0.535 | 86.0 | 0.313 | 84.0 | 0.115 |
 Yes | 41 | 72.7 |  | 65.5 |  | 91.5 |  | 67.9 |  |
Hemoglobin (g/dL) | |||||||||
  ≥ 12 | 84 | 76.7 | 0.914 | 68.0 | 0.398 | 87.5 | 0.574 | 76.6 | 0.765 |
  < 12 | 15 | 79.4 |  | 80.0 |  | 93.3 |  | 80.0 |  |
CRP (mg/dL) | |||||||||
  ≤ 0.14 | 61 | 84.5 | 0.050 | 79.3 | 0.023 | 92.6 | 0.376 | 84.5 | 0.015 |
  > 0.14 | 33 | 69.3 |  | 57.1 |  | 84.1 |  | 66.5 |  |
ESR (mm/h) | |||||||||
  ≤ 15 | 47 | 91.2 | 0.001 | 89.1 | 0.003 | 97.7 | 0.035 | 93.5 | 0.001 |
  > 15 | 44 | 69.4 |  | 57.8 |  | 80.6 |  | 67.4 |  |
NLR | |||||||||
  ≤ 1.95 | 52 | 84.0 | 0.054 | 78.4 | 0.174 | 89.3 | 0.793 | 84.4 | 0.170 |
  > 1.95 | 45 | 70.2 |  | 63.0 |  | 89.0 |  | 69.9 |  |